COBISS Kooperativni online bibliografski sistem in servisi COBISS
Nadica Sibinovska
Osebna bibliografija za obdobje 2019-2022
2019
1.
SIBINOVSKA, Nadica, ŽAKELJ, Simon, KRISTAN, Katja. Suitability of RPMI 2650 cell models
for nasal drug permeability prediction. European journal of pharmaceutics and biopharmaceutics. [Print ed.]. 2019, vol. 145, str. 85-95, ilustr. ISSN 0939-6411. https://www.sciencedirect.com/science/article/pii/S0939641119308732, DOI: 10.1016/j.ejpb.2019.10.008. [COBISS.SI-ID 1518174]
2020
2.
BERGINC, Katja, SIBINOVSKA, Nadica, ŽAKELJ, Simon, TRONTELJ, Jurij, LEGEN, Igor. Biopharmaceutical
classification of desloratadine - not all drugs are classified the easy way. Acta pharmaceutica. 2020, vol. 70, iss. 2, str. 131-144, ilustr. ISSN 1330-0075. https://sciendo.com/article/10.2478/acph-2020-0006, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.2478/acph-2020-0006. [COBISS.SI-ID 4797553]
projekt: P1-0189; financer: ARRS
projekt: P1-0189; financer: ARRS
3.
SIBINOVSKA, Nadica, ŽAKELJ, Simon, KRISTAN, Katja. In vitro cell models for nasal
drug permeability determination. V: Third ALL WGs UNGAP Meeting, 11th - 12th February 2020 : Ljubljana, Slovenia. Ljubljana: [s. n.], 2020. 1 str., ilustr. [COBISS.SI-ID 1553502]
4.
SIBINOVSKA, Nadica, ŽAKELJ, Simon, ROŠKAR, Robert, KRISTAN, Katja. Suitability and
functional characterization of two Calu-3 cell models for prediction of drug permeability
across the airway epithelial barrier. International journal of pharmaceutics. [Print ed.]. 2020, vol. 585, str. 1-10. ISSN 0378-5173. DOI: 10.1016/j.ijpharm.2020.119484. [COBISS.SI-ID 18189059]
2021
5.
TRATNJEK, Larisa, SIBINOVSKA, Nadica, KRISTAN, Katja (avtor, korespondenčni avtor),
ERDANI-KREFT, Mateja (avtor, korespondenčni avtor). In vitro ciliotoxicity and cytotoxicity
testing of repeated chronic exposure to topical nasal formulations for safety studies.
Pharmaceutics. [Online ed.]. 2021, vol. 13, iss. 11, str. 1-20, ilustr. ISSN 1999-4923. https://www.mdpi.com/1999-4923/13/10/1739, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.3390/pharmaceutics13111750. [COBISS.SI-ID 81714179]
projekt: J7-2594; financer: Slovenian Research Agency; MRIC UL
projekt: J7-2594; financer: Slovenian Research Agency; MRIC UL
6.
SIBINOVSKA, Nadica, BOŽIČ, Dane, BOŠKOVIĆ, Marija, KRISTAN, Katja. Prediction of pharmacokinetic
studies outcome for locally acting nasal sprays by using different in vitro methods.
International journal of pharmaceutics. [Print ed.]. 2021, vol. 601, str. 1-11, ilustr. ISSN 0378-5173. DOI: 10.1016/j.ijpharm.2021.120569. [COBISS.SI-ID 61135875]
7.
TRATNJEK, Larisa, SIBINOVSKA, Nadica, KRALJ, Slavko, MAKOVEC, Darko, KRISTAN, Katja,
ERDANI-KREFT, Mateja. Standardization of esophageal adenocarcinoma in vitro model
and its applicability for model drug testing. Scientific reports. mar. 2021, vol. 11, str. 1-23, ilustr. ISSN 2045-2322. https://www.nature.com/articles/s41598-021-85530-w.pdf, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.1038/s41598-021-85530-w. [COBISS.SI-ID 56692995]
8.
SIBINOVSKA, Nadica. Suitability and reliability of in vitro epithelial cell models for nasal and pulmonary
drug permeability determination : doctoral thesis = Ustreznost in zanesljivost in
vitro epitelijskih celičnih modelov za določanje nazalne in pulmonalne permeabilnosti
zdravilnih učinkovin : doktorska disertacija. Ljubljana: [N. Sibinovska], 2021. 185 str., graf. prikazi, tabele. Repozitorij Univerze v Ljubljani – RUL, http://www.dlib.si/details/URN:NBN:SI:doc-UPSGVVJI. [COBISS.SI-ID 80440579]
2022
9.
SIBINOVSKA, Nadica, ŽAKELJ, Simon, TRONTELJ, Jurij, KRISTAN, Katja. Applicability
of RPMI 2650 and Calu-3 cell models for evaluation of nasal formulations. Pharmaceutics. [Online ed.]. 2022, vol. 14, issue 2, art.369, str. 1-19. ISSN 1999-4923. Repozitorij Univerze v Ljubljani – RUL, DOI: 10.3390/pharmaceutics14020369. [COBISS.SI-ID 107048707]
projekt: P1-0189; financer: ARRS
projekt: P1-0189; financer: ARRS